GlassScriptPhysician profile
Lora K Whitt
NPI 1316602881
$2,448.08
in general payments reported to CMS, 2019-2025
26 companies · $417 in 2025
The $417 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $24.51 · 2022: $1,009 · 2023: $543 · 2024: $455 · 2025: $417.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,415.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,414.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $322.79 | 2022-2024 | |
| Biogen, INC. | $233.61 | 2024-2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $232.77 | 2022-2025 | |
| Myovant Sciences INC. | $207.07 | 2022 | |
| Amgen INC. | $206.03 | 2022-2024 | Evenity, Prolia |
| Sumitomo Pharma America, INC. | $203.61 | 2023-2025 | Myfembree, Gemtesa |
| Astellas Pharma US INC | $147.23 | 2023-2025 | Veozah |
| Agile Therapeutics, INC. | $106.08 | 2021-2022 | |
| Sage Therapeutics, LLC | $96.85 | 2022-2023 | |
| Ethicon US, LLC | $74.88 | 2025 | Stratafix, Vistaseal, Evarrest |
| Hologic Sales and Service, LLC | $65.27 | 2024-2025 | Coolseal Generator, Novasure, Myosure Tissue Removal Device |
| Bayer Healthcare Pharmaceuticals INC. | $62.89 | 2022-2025 | |
| Novo Nordisk INC | $61.58 | 2023 | Wegovy |
| Pfizer INC. | $61.04 | 2022-2023 | |
| Urovant Sciences INC | $59.47 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $48.84 | 2024-2025 | Slynd |
| Daiichi Sankyo INC. | $46.97 | 2022 | |
| Shield Therapeutics INC | $41.09 | 2023 | Accrufer |
| Glaxosmithkline, LLC. | $37.71 | 2022 | |
| Avion Pharmaceuticals | $30.92 | 2022 | |
| Organon LLC | $28.93 | 2023-2025 | Nexplanon |
| Merck Sharp & Dohme LLC | $16.32 | 2023 | Gardasil 9 |
| Evofem Biosciences, INC. | $15.86 | 2022 | |
| Exact Sciences Corporation | $14.12 | 2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $13.21 | 2024 | Zepbound |
| Coloplast Corp | $12.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lora Whitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.